GC Gel-Filled Testicular Implant
A testicular implant with highly cohesive silicone gel filling and five size options.
Product detail →Home / Products / AndroPeyronie
Andrology Penile traction device
AndroPeyronie penile traction device.
A medical device applying controlled mechanical traction for non-surgical, non-invasive conservative management of Peyronie's disease. The content is institutional technical information for physicians, hospitals and procurement teams.
01 Overview
Traction therapy in Peyronie's disease.
Peyronie's disease affects roughly 3–9% of adult men and is characterised by the development of fibrous scar tissue (plaque) in the tunica albuginea, leading to penile curvature, shortening, narrowing and, in many cases, psychological impact. AndroPeyronie is one of the few conservative treatment options that can be considered in both the active and the stable phase of the disease.
The device applies controlled, adjustable and continuous traction to the penile shaft; it requires no surgery or injection and can be applied by the patient at home. Lisa Health provides hospitals and physicians with documented supply of the product, use-protocol documentation and institutional paperwork support. The final indication, phase determination and patient suitability are determined solely by a specialist physician.
02 Mechanism of action
Tissue adaptation through mechanotransduction.
Mechanical traction induces mechanotransduction, the process of cellular adaptation that develops in response to controlled physical force. Traction applied consistently to the penile shaft supports the following processes:
- Fibroblast stimulation: plaque fibroblasts respond to mechanical loading and reorganise the collagen architecture.
- Angiogenesis: the formation of new capillaries in the traction area improves local tissue oxygenation.
- Cellular proliferation: new cellular growth at the traction interface gradually supports tissue length.
- Plaque softening: repeated cyclic loading remodels the dense fibrous plaque matrix over time.
03 Treatment algorithm
A comparison of conservative and surgical options.
The table below summarises the approaches frequently considered in Peyronie's disease for institutional decision-making. Selection and sequencing are made solely on the clinical judgement of a specialist physician.
| Criterion | Traction (AndroPeyronie) | Collagenase (Xiaflex®) | Plication surgery |
|---|---|---|---|
| Invasiveness | Non-invasive | Intralesional injection | Surgery |
| Applicable phase | Active and stable | Active (stable contraindicated) | Stable phase only |
| Length preservation | Primary benefit | Partial | Shortening possible |
| Curvature correction | Moderate (10–25°) | Moderate (avg. ~17°) | High (>50°) |
| Care setting | Home use | Clinical | Hospital |
| Position in the EAU guidelines | Indicated | Recommended | Recommended |
04 Clinical evidence context
A conservative option included in the guidelines.
Penile traction therapy appears in the guidelines of the European Association of Urology (EAU) and the American Urological Association (AUA) as a conservative treatment option in Peyronie's disease, and is considered in particular for the preservation of penile length. Published case series report an average curvature reduction of 10–25 degrees and a length preservation/gain of 0.5–1.5 cm with regular adherence to a 3–6 month protocol.
Combination therapy: AndroPeyronie may be compatible with concurrent medical therapy. Several published protocols combine traction with collagenase injections (Xiaflex® / Xiapex®) or oral pharmacotherapy (pentoxifylline, vitamin E) for improved outcomes. All combination therapy decisions must be assessed by an experienced urologist.
05 Technical summary
Institutional evaluation table.
| Device type | Penile traction device |
|---|---|
| Indication | Peyronie's disease (conservative management) |
| Mechanism | Controlled lengthening (mechanotransduction) |
| Daily use | 3–8 hours per day (may be divided into sessions) |
| Protocol duration | Minimum 3–6 months |
| Material | Medical-grade plastic and silicone |
| Adjustment | Continuously adjustable tension |
| Certification | CE Class I medical device |
| Target audience | Urology/andrology physicians, hospitals and procurement units |
06 Use protocol
A five-step traction protocol under physician supervision.
The effectiveness of AndroPeyronie depends on consistent and correct use. The protocol is planned and monitored under specialist physician supervision.
- 01 · Initial assessment: diagnosis of Peyronie's disease, degree of curvature and phase determination by a urologist.
- 02 · Start at low tension: tissue adaptation with a low tension setting during the first weeks.
- 03 · Daily use of 3–8 hours: consistent daily application, which may be divided into sessions.
- 04 · Assessment at month 3: objective measurement of change in curvature and length at a urologist review.
- 05 · Full protocol: a full six-month protocol; combination therapy planning if considered necessary.
07 Questions & answers
Frequently asked institutional questions.
For which indication is AndroPeyronie considered?
AndroPeyronie is a penile traction device designed for non-surgical conservative management of Peyronie's disease; it can be considered in both the active and the stable phase of the disease. Clinical suitability and phase determination are established solely by a specialist physician.
What place does traction therapy have in the guidelines?
Penile traction appears in the guidelines of the European Association of Urology (EAU) and the American Urological Association (AUA) as a conservative treatment option in Peyronie's disease; it is considered in particular for the preservation of penile length.
How is the device used on a daily basis?
The standard protocol is 3–8 hours of use per day, optionally divided into several sessions, maintained for a minimum of 3–6 months. Consistency of use is the most important determinant of the outcome; application is planned under specialist physician supervision.
Can it be used together with combination therapy?
Traction may be compatible with medical therapies such as concurrent collagenase injections or oral pharmacotherapy. All combination therapy decisions must be assessed by an experienced urologist.
08 Conservative approach
A non-invasive first step before surgery.
AndroPeyronie is a conservative option that prioritises preservation of penile length and can be considered even in the active phase, where surgical correction is contraindicated. The device is designed to be worn under clothing and can be applied by the patient at home. The use protocol, conformity documentation and technical file are compiled according to institutional processes for physicians, hospitals and procurement units.
Request a quotation →
09 Related products
Other solutions in the same portfolio.
Explore the other solutions in the urology and andrology portfolio.
Request product information and a quotation for AndroPeyronie.
State your institution type and the documents you need, and we will respond with the use protocol and a quotation schedule.